Satellos Bioscience Inc
(MSCLF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,125 | -968 | -817 | -663 | -1,290 |
| Depreciation Amortization | 21 | 12 | 8 | 4 | 10 |
| Other Working Capital | 7 | -38 | -19 | -30 | -890 |
| Other Operating Activity | 91 | 46 | 34 | 27 | -50 |
| Operating Cash Flow | $-1,007 | $-947 | $-794 | $-662 | $-2,220 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -382 | -383 | N/A | N/A |
| PPE Investments | -3 | -3 | -3 | -1 | -1 |
| Sale Of Investment | N/A | N/A | N/A | -532 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1,431 |
| Investing Cash Flow | $-3 | $-385 | $-387 | $-534 | $1,430 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $0 |
| Exchange Rate Effect | -43 | N/A | N/A | N/A | 90 |
| Beginning Cash Position | 2,835 | 2,093 | 2,116 | 2,102 | 2,650 |
| End Cash Position | 1,783 | 760 | 935 | 906 | 1,960 |
| Net Cash Flow | $-1,052 | $-1,332 | $-1,181 | $-1,196 | $-690 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,007 | -947 | -794 | -662 | -2,220 |
| Capital Expenditure | -3 | -3 | -3 | -1 | N/A |
| Free Cash Flow | -1,010 | -950 | -797 | -664 | -2,220 |